SCHEMBL4189953

SCHEMBL4189953

CCOC(=O)CCCN1C(=O)N(c2ccc(C#N)c(C(F)(F)F)c2)C(=O)C1(C)C

nearest known ligand 0.72

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AR P10275 5/20 0.72
PGR P06401 1/20 0.72
HDAC1 Q13547 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025056 0.89 AR (0.72) ARPGRHDAC1
SCHEMBL4196099 0.89 AR (0.66) ARPGR
SCHEMBL31743441 0.88 AR (0.68) ARPGRHDAC1
SCHEMBL4204207 0.88 AR (0.82) ARPGRHDAC1
SCHEMBL8924917 0.88 AR (0.56) ARPGRHDAC1
SCHEMBL8926413 0.86 AR (0.53) ARPGRHDAC1
SCHEMBL633929 0.86 AR (0.88) ARPGRHDAC1
SCHEMBL4195979 0.85 AR (0.67) ARPGRHDAC1
SCHEMBL2694365 0.85 AR (0.94) ARPGR
SCHEMBL27966873 0.85 AR (0.76) ARPGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009097996-A1 USE OF SUBSTITUTED PHENYLIMIDAZOLIDINES FOR PRODUCING MEDICAMENTS FOR TREATING METABOLIC SYNDROME SANOFI-AVENTIS (FR) 2009-08-13 WO disclosed
US-6162444-A Cosmetic or pharmaceutical compositions HOECHST MARION ROUSSEL (FR) 2000-12-19 US disclosed
US-RE35956-E Phenylimidazolidines having antiandrogenic activity ROUSSEL UCLAF (FR) 1998-11-10 US disclosed
US-5627201-A Phenylimidazolidines having antiandrogenic activity ROUSSEL UCLAF (FR) 1997-05-06 US disclosed
US-5411981-A Phenylimidazolidines having antiandrogenic activity ROUSSEL UCLAF (FR) 1995-05-02 US disclosed